Thrombocytopenia, Immune
2 clinical trials · Condition
◉ Watch Thrombocytopenia, Immune
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients (NCT07455006) | Qilu Pharmaceutical Co., Ltd. | 2026-04-20 |
| A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia (NCT05785819) | Veralox Therapeutics | 2023-09-26 |
Track Thrombocytopenia, Immune automatically
Every clearance here is in the API, with alerts when new ones post.